The expression of FBXO22, VHL, HIF-1α, and VEGFA was detected by IHC staining using anti-FBXO22, VHL, HIF-1α, and VEGFA antibodies in the tissue sections of glioma patients. This evidence concerns the gene FBXO22 and central nervous system cancer.